2007
DOI: 10.1158/0008-5472.can-07-1827
|View full text |Cite
|
Sign up to set email alerts
|

Suppression of PTEN Expression Is Essential for Antiapoptosis and Cellular Transformation by Oncogenic Ras

Abstract: Ras is one of the most commonly mutated oncogenes in the array of human cancers. The mechanism by which Ras induces cellular transformation is, however, not fully elucidated. We present here evidence that oncogenic Ras suppresses the expression of the tumor suppressor phosphatase and tensin homologue deleted from chromosome 10

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

4
66
2
1

Year Published

2008
2008
2018
2018

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 63 publications
(73 citation statements)
references
References 33 publications
4
66
2
1
Order By: Relevance
“…Accordingly, the PTEN and c-Jun levels inversely correlate in a panel of tumor cell lines. Although c-Jun was shown to inhibit the PTEN promoter, the PTEN 5 0 -flanking region targeted by c-Jun was not identified unambiguously (Hettinger et al, 2007;Vasudevan et al, 2007). In our RAS-inducible cell system, transcriptional inhibition does not seem to play a major role in the downregulation of PTEN, as the effect of RAS is entirely relieved by the inhibition of miR-21 (Figure 7c) affecting PTEN at the post-transcriptional level (Meng et al, 2007).…”
Section: Discussionmentioning
confidence: 74%
See 1 more Smart Citation
“…Accordingly, the PTEN and c-Jun levels inversely correlate in a panel of tumor cell lines. Although c-Jun was shown to inhibit the PTEN promoter, the PTEN 5 0 -flanking region targeted by c-Jun was not identified unambiguously (Hettinger et al, 2007;Vasudevan et al, 2007). In our RAS-inducible cell system, transcriptional inhibition does not seem to play a major role in the downregulation of PTEN, as the effect of RAS is entirely relieved by the inhibition of miR-21 (Figure 7c) affecting PTEN at the post-transcriptional level (Meng et al, 2007).…”
Section: Discussionmentioning
confidence: 74%
“…During tumorigenesis, AP-1 regulates a wide variety of target genes, positively controlling cell proliferation, invasion and angiogenesis (Eferl and Wagner, 2003;Ozanne et al, 2007) On the other hand, cell cycle inhibitory and proapoptotic tumor suppressors, such as p16 INK4A and PTEN, are usually repressed by c-Jun/AP-1 (Bakiri et al, 2000;Hettinger et al, 2007;Vasudevan et al, 2007). Although the AP-1-induced promoters are controlled by AP-1 binding to TRE elements, the genes inhibited by AP-1 do not share a common regulatory mechanism, thus suggesting the role of indirect control networks in AP-1-mediated gene repression.…”
Section: Introductionmentioning
confidence: 99%
“…Physiologically, PTEN-dependent early endodermal morphogenesis seems to require the Erk, but not the Akt, pathway (36). Furthermore, in Rasinduced oncogenic transformation, PTEN apoptotic function is suppressed via the Raf-Mek-Erk pathway (37). Recent publications using human breast cancer cell lines support the notion that PI3K inhibition can involve an ERK-dependent component (38,39).…”
Section: Discussionmentioning
confidence: 99%
“…16 -18 Interestingly, although there was a mild increase in the expression of total Rap1b, its GTP activity was reduced under high-glucose ambience, which probably was due to increased expression of GAP (Figures 1 and 2). Because Rap1b-related oncogenic Ras and Raf suppress the apoptotic gene PTEN via the Raf-MEK-extracellular signalregulated kinase-c-Jun pathway to induce cellular transformation and growth, 31 it may mean that Rap1b may exert a protective role in the scenario of glucose-induced injury leading to apoptosis. This seems to be the case because transfection of Rap1b resulted in the normalization of Bcl-2 and Bax expression, mitochondrial ⌬⌿ m with reduction in the leakage of cytochrome C, mtDNA damage, and apoptosis (Figures 2 through 4).…”
Section: Discussionmentioning
confidence: 99%